Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-19-055556
Filing Date
2019-02-28
Accepted
2019-02-28 07:24:11
Documents
77
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d683457d10k.htm 10-K 1216013
2 EX-21.1 d683457dex211.htm EX-21.1 1620
3 EX-23.1 d683457dex231.htm EX-23.1 2261
4 EX-31.1 d683457dex311.htm EX-31.1 6333
5 EX-31.2 d683457dex312.htm EX-31.2 6320
6 EX-32.1 d683457dex321.htm EX-32.1 3945
7 EX-32.2 d683457dex322.htm EX-32.2 3932
14 GRAPHIC g683457g89w38.jpg GRAPHIC 92027
  Complete submission text file 0001193125-19-055556.txt   5147466

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT srra-20181231.xml EX-101.INS 821950
9 XBRL TAXONOMY EXTENSION SCHEMA srra-20181231.xsd EX-101.SCH 53240
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20181231_cal.xml EX-101.CAL 72279
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20181231_def.xml EX-101.DEF 176046
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20181231_lab.xml EX-101.LAB 473314
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20181231_pre.xml EX-101.PRE 319833
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37490 | Film No.: 19640426
SIC: 2834 Pharmaceutical Preparations